To understand what that means for safety, see the treatment options section
Ivy League formulated Developed with an expert advisory board that includes an Ivy League doctor
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
That price frustration is what shaped my decision to develop my own blend
Reported outcomes can vary by trial design, population, and estimand, and individual results vary